{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:50:58Z","timestamp":1790369458120,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T00:00:00Z","timestamp":1103673600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00198-004-1798-8","type":"journal-article","created":{"date-parts":[[2004,12,21]],"date-time":"2004-12-21T12:57:41Z","timestamp":1103633861000},"page":"1281-1290","source":"Crossref","is-referenced-by-count":104,"title":["Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials"],"prefix":"10.1007","volume":"16","author":[{"given":"Jennifer A.","family":"Knopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry M.","family":"Diner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Lyritis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,12,22]]},"reference":[{"key":"1798_CR1","unstructured":"Goeree R, O\u2019Brien B, Petitte DB et al (1996) An assessment of the burden of illness due to osteoporosis in Canada. J Soc Obstet Gynaecol Can 18 July [Suppl 1]:5\u201324"},{"key":"1798_CR2","unstructured":"NIH Consensus Statement. (2000) Mar 27\u201329; 17(1):1\u201345"},{"key":"1798_CR3","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/oxfordjournals.aje.a115204","volume":"129","author":"Melton","year":"1989","unstructured":"Melton LJ 3rd, Kan SH, Frye KM et al (1989) Epidemiology of vertebral fractures in women. Am J Epidemiol 129:1000\u20131001","journal-title":"Am J Epidemiol"},{"key":"1798_CR4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","volume":"9","author":"Melton","year":"1992","unstructured":"Melton LJ 3rd, Chrischilles EA, Lane AW, Riggs BL (1992) How many women have osteoporosis? J Bone Miner Res 9:1005\u20131010","journal-title":"J Bone Miner Res"},{"key":"1798_CR5","first-page":"22","volume":"49","author":"Lukert","year":"1994","unstructured":"Lukert BP (1994) Vertebral compression fractures: how to manage pain, avoid disability. Geriatrics 49(2):22\u201326","journal-title":"Geriatrics"},{"key":"1798_CR6","doi-asserted-by":"crossref","unstructured":"Lyritis GP, Mayasis B, Tsakalakos N, Lambropoulos A, Gazi S, Karachalios TH et al (1989) The natural history of the osteoporotic vertebral fracture. Clin Rheumatol 8[Suppl 2]:66\u201369","DOI":"10.1007\/BF02207237"},{"key":"1798_CR7","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2165\/00002512-199608050-00006","volume":"8","author":"Plosker","year":"1996","unstructured":"Plosker GL, McTavish D (1996) Intranasal Salcatonin (Salmon Calcitonin) A review of its pharmacological properties and role in the management of postmenopausal osteoporosis. Drugs Aging 8(5):378\u2013400","journal-title":"Drugs Aging"},{"key":"1798_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2165\/00002512-199609050-00002","volume":"9","author":"Drage","year":"1996","unstructured":"Drage MP, Schug SA (1996) Analgesia in the elderly. Practical treatment recommendations. Drugs Aging 9(5):311\u2013318","journal-title":"Drugs Aging"},{"key":"1798_CR9","doi-asserted-by":"crossref","unstructured":"Gennari C (1989) Salmon calcitonin (Miacalcic) nasal spray in prevention and treatment of osteoporosis. Clin Rheumatol 8[Suppl 2]:61\u201365","DOI":"10.1007\/BF02207236"},{"key":"1798_CR10","first-page":"2160","volume":"44","author":"Maksymowych","year":"1998","unstructured":"Maksymowych WP (1998) Managing acute osteoporotic vertebral fractures with calcitonin. Can Fam Physician 44:2160\u20132166","journal-title":"Can Fam Physician"},{"key":"1798_CR11","first-page":"962","volume":"155","author":"Siminoski","year":"1996","unstructured":"Siminoski K, Josse RG (1996) Calcitonin in the treatment of osteoporosis. Can Med Assoc J 155:962\u2013965","journal-title":"Can Med Assoc J"},{"key":"1798_CR12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00003081-199806000-00005","volume":"4","author":"Schulz","year":"1998","unstructured":"Schulz KF (1998) Randomized controlled trials. Clin Obstet Gynecol 4:245\u2013256","journal-title":"Clin Obstet Gynecol"},{"key":"1798_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll E, Jenkinson C, Reynolds DJM, Gavagham DJ et al (1996) Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1\u201312","journal-title":"Control Clin Trials"},{"key":"1798_CR14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","volume":"273","author":"Schulz","year":"1995","unstructured":"Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 273:408\u2013412","journal-title":"JAMA"},{"key":"1798_CR15","unstructured":"Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando, FL, USA"},{"key":"1798_CR16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"Begg","year":"1994","unstructured":"Begg CB, Mazundar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"1798_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"1798_CR18","unstructured":"De Pascalis MA, Fletzer DA, Spirito A (1983) Clinico-statistical study in patients with an arthrosis-osteoporosis picture in its painful stage treated with synthetic salmon calcitonin. [Studio clinico statistico su pazienti affetti da quadri di artrosi-osteoporosi in fase algica trattati con calcitonina sintetica di salmone.] Clin Ther 107(3):177\u2013184"},{"key":"1798_CR19","first-page":"83","volume":"28","author":"Kapuscinski","year":"1996","unstructured":"Kapuscinski P, Talalaj M, Borowicz J, Marcinowska-Suchowierska E, Brzozowski R (1996) An analgesic effect of synthetic human calcitonin in patients with primary osteoporosis. Mater Med Pol 28(3):83\u201386","journal-title":"Mater Med Pol"},{"key":"1798_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s002239900284","volume":"61","author":"Combe","year":"1997","unstructured":"Combe B, Cohen C, Aubin F (1997) Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin. Calcif Tissue Int 61:10\u201315","journal-title":"Calcif Tissue Int"},{"key":"1798_CR21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1742-1241.2001.tb11111.x","volume":"55","author":"Dursun","year":"2001","unstructured":"Dursun N, Dursun E, Yalcin S (2001) Comparison of alendronate, calcitonin and calcium treatments in postmenopausal osteoporosis. Int J Clin Pract 55:505\u2013509","journal-title":"Int J Clin Pract"},{"key":"1798_CR22","unstructured":"Palmieri LR (1993) Effect of s-calcitonin on pain related to recent osteoporotic vertebral fractures: a single-blind controlled clinical study against ipriflavone. [Effetto della calcitonina di salmone sul dolore provocato da recenti fratture vertebrali osteoporotiche: studio contollato in singolo cieco verso ipriflavone.] Acta Toxicol Ther XIV(2):73\u201383"},{"key":"1798_CR23","unstructured":"Abellan Perez M, Bayina Garcia FJ, Calabozo M, Carpintero Benitez P, Figueroa Pedrosa M, Fernandez Crisostomo C et al (1995) Multicentric comparative study of synthetic salmon calcitonin nasally administered in the treatment of established postmenopausal osteoporosis. [Estudio comparativo multicentrico de la calcitonina sintetica de salmon, administrada por via nasal enel tratamiento de la osteoporosis postmenopausica establecida.] Ann Med Intern 12:12\u201316"},{"key":"1798_CR24","unstructured":"Hernandez Cassis C, Cure Cure C, Hernandez Cassis S, Latorre A, Cure J, Crespo S et al (1985) Use of calcitonin in the multifactorial treatment of osteoporosis. [Uso de la calcitonina en el tratamiento multifactorial de la osteoporosis.] Salud Uninorte 2(1):3\u201312"},{"key":"1798_CR25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02555897","volume":"49","author":"Ljunghall","year":"1991","unstructured":"Ljunghall S, Gardsell P, Johnell O, Larsson K, Lindh E, Obrant K et al (1991) Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind study. Calcif Tissue Int 49:17\u201319","journal-title":"Calcif Tissue Int"},{"key":"1798_CR26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0011-393X(05)80278-4","volume":"55","author":"Mannarini","year":"1994","unstructured":"Mannarini M, Fincato G, Galimberti S, Maderna M, Greco F (1994) Analgesic effect of salmon calcitonin suppositories in patients with bone pain. Curr Ther Res Clin Exp 55:1079\u20131083","journal-title":"Curr Ther Res Clin Exp"},{"key":"1798_CR27","first-page":"211","volume":"22","author":"Orimo","year":"1994","unstructured":"Orimo H, Fujita T, Yoshikawa S, Inoue T, Morita R (1994) Clinical study of SMC 20\u2013051 nasal spray in pain due to osteoporosis. Clin Eval 22:211\u2013231","journal-title":"Clin Eval"},{"key":"1798_CR28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/09513599909167526","volume":"13","author":"Peichl","year":"1999","unstructured":"Peichl P, Rintelen B, Kumpan W Broll H (1999) Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy. Gynecol Endocrinol 13:7\u201314","journal-title":"Gynecol Endocrinol"},{"key":"1798_CR29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF03324278","volume":"6","author":"Pontiroli","year":"1994","unstructured":"Pontiroli AE, Pajetta E, Scaglia L, Rubinacci A, Resmini G, Arrigoni M et al (1994) Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: A double-blind, double-placebo study. Aging Clin Exp Res 6:459\u2013463","journal-title":"Aging Clin Exp Res"},{"key":"1798_CR30","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1055\/s-2008-1065138","volume":"115","author":"Ringe","year":"1990","unstructured":"Ringe JD (1990) Treatment of primary osteoporosis with calcium and salmon calcitonin. Dtsch Med Wochenschr 115:1176\u20131182","journal-title":"Dtsch Med Wochenschr"},{"key":"1798_CR31","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1345\/aph.1C350","volume":"37","author":"Blau","year":"2003","unstructured":"Blau LA, Hoehns JD (2003) Analgesic efficacy of calcitonin for vertebral fracture pain. Ann Pharmacother 37:564\u2013570","journal-title":"Ann Pharmacother"},{"key":"1798_CR32","doi-asserted-by":"crossref","unstructured":"Gennari C (2002) Analgesic effect of calcitonin in osteoporosis. Bone 30 [Suppl 5]: 67S\u201370S","DOI":"10.1016\/S8756-3282(02)00713-5"},{"key":"1798_CR33","doi-asserted-by":"crossref","unstructured":"Gennari C, Agnusdei D, Camporeale A (1991) Use of calcitonin in the treatment of bone pain associated with osteoporosis. Calcif Tissue Int 49 [Suppl 2]:S9\u2013S13","DOI":"10.1007\/BF02561370"},{"key":"1798_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/qjmed\/92.3.143","volume":"92","author":"Kanis","year":"1999","unstructured":"Kanis JA, McCloskey EV (1999) Effect of calcitonin on vertebral and other fractures. QJM 92:143\u2013149","journal-title":"QJM"},{"key":"1798_CR35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s001980200118","volume":"13","author":"Silverman","year":"2002","unstructured":"Silverman SL, Azria M (2002) The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 13:858\u2013867","journal-title":"Osteoporos Int"},{"key":"1798_CR36","doi-asserted-by":"crossref","unstructured":"Lyritis GP, Trovas G (2002) Analgesic effects of calcitonin. Bone 30 [Suppl 5]:71S\u201374S","DOI":"10.1016\/S8756-3282(02)00714-7"},{"key":"1798_CR37","unstructured":"Spigset O, Mjorndal T, Vinge E, Lerner UH (1993) Calcitonin as medication in pain? [Kalcitonin som lakemedel vid smarta?] Nor Med 108(2):54\u201357"},{"key":"1798_CR38","unstructured":"Kelly Mexia L, Gonzalez Ibanez J (1988) Effectiveness of synthetic salmon calcitonin in the osteoporosis of the spine. [Eficacia de la calcitonina sintetica de salmon en episodios agudos de fracturas por osteoporosis de columna vertebral.] Compend Invest Clin Latin 8(2):23\u201331"},{"key":"1798_CR39","unstructured":"Attali G, Levernieux J, Caulin F (1987) Recent crush fracture syndrome. Effect of salmon calcitonin. Results of three double-blind studies and one open study. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis 1987\/international symposium on osteoporosis. Osteopress, Copenhagen, pp\u00a0930\u2013932"},{"key":"1798_CR40","doi-asserted-by":"crossref","unstructured":"Dilsen G, Sindel D, An C (1996) Effect of nasal calcitonin on pain in osteoporotic patients with vertebral fractures. Osteoporos Int 6 [Suppl 1]:259","DOI":"10.1007\/BF02500571"},{"key":"1798_CR41","unstructured":"Szejnfeld VL, Ferraz MB, Sato EI, Atra E (1991) Analgesic effect of salmon calcitonin in patients with osteoporosis: randomized double-blind method. [Efeito analgesico da calcitonina de salmao em pacientes acometidos por osteoporose: estudo duplo cego randomizado.] Rev Bras Orthop 26(3):81\u201385"},{"key":"1798_CR42","unstructured":"Arinoviche R, Arriagada M, Jacobelli S, Massardo L, Rivero S, Aris H et al (1987) Analgesic effect of calcitonin in osteoporotic patients with acute vertebral fracture. [Calcitonina en dolor agudo por fractura vertebral en osteoporosis.] Rev Med Chil 115:1039\u20131043"},{"key":"1798_CR43","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02555844","volume":"49","author":"Lyritis","year":"1991","unstructured":"Lyritis GP, Tsakalakos N, Magiasis B, Karachalios T, Yiatzides A, Tsekoura M (1991) Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. Calcif Tissue Int 49:369\u2013372","journal-title":"Calcif Tissue Int"},{"key":"1798_CR44","doi-asserted-by":"crossref","unstructured":"Lyritis GP, Paspati I, Karachalios T, Ioakimidis D, Skarantavos G, Lyritis PG (1997) Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. Acta Orthop Scand 68 [Suppl 275]:112\u2013114","DOI":"10.1080\/17453674.1997.11744761"},{"key":"1798_CR45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002508-199912000-00004","volume":"15","author":"Lyritis","year":"1999","unstructured":"Lyritis GP, Ioannidis GV, Karachalios T, Roidis N, Kataxaki E, Papaioannou N et al (1999) Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: A prospective double blind, randomized, placebo-controlled clinical study. Clin J Pain 15:284\u2013289","journal-title":"Clin J Pain"},{"key":"1798_CR46","first-page":"205","volume":"11","author":"Pun","year":"1989","unstructured":"Pun KK, Chan LWL (1989) Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 11:205\u2013209","journal-title":"Clin Ther"},{"key":"1798_CR47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","volume":"357","author":"Moher","year":"2001","unstructured":"Moher D, Schultz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191\u20131194","journal-title":"Lancet"},{"key":"1798_CR48","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJM199708213370806","volume":"337","author":"LeLorier","year":"1997","unstructured":"LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F (1997) Discrepancies between meta-analysis and subsequent large randomized, controlled trials. N Engl J Med 337:536\u2013542","journal-title":"N Engl J Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-004-1798-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-004-1798-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T03:28:44Z","timestamp":1705462124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-004-1798-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,22]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["1798"],"URL":"https:\/\/doi.org\/10.1007\/s00198-004-1798-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,22]]}}}